Disclosure Of Entity's Operating Segments [Text Block]

GENFLOW BIOSCIENCES PLC - Filing #5893549

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)
- GBP
- GBP
Profit (loss) before tax
1,587,235 GBP
1,860,345 GBP
Profit (loss) from continuing operations
1,587,235 GBP
1,860,345 GBP
Profit (loss)
1,587,235 GBP
- GBP
- GBP
- GBP
1,587,235 GBP
- GBP
1,860,345 GBP
- GBP
1,860,345 GBP
- GBP
Assets
385,908 GBP
1,071,653 GBP
Liabilities
788,916 GBP
571,960 GBP
Cash flows from (used in) operating activities
1,082,273 GBP
1,660,875 GBP
Cash flows from (used in) investing activities
- GBP
2,439 GBP
Cash flows from (used in) financing activities
656,635 GBP
- GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.